Artículo Destacado en trastornos del movimiento

Clozapine Therapy and CYP Genotype

Dean L, Kane M.

2016 Jun 8 [updated 2021 May 26]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

Validity and reliability of the Geriatric Anxiety Inventory in Parkinson's disease.

Matheson SF, Byrne GJ, Dissanayaka NN, Pachana NA, Mellick GD, O'Sullivan JD, Silburn PA, Sellbach A, Marsh R.

Australas J Ageing. 2012 Mar;31(1):13-6. doi: 10.1111/j.1741-6612.2010.00487.x.

The effect of motion content in action naming by Parkinson's disease patients.

Herrera E, Rodríguez-Ferreiro J, Cuetos F.

Cortex. 2012 Jul;48(7):900-4. doi: 10.1016/j.cortex.2010.12.007.

Probabilistic subgroup identification using Bayesian finite mixture modelling: a case study in Parkinson's disease phenotype identification.

White N, Johnson H, Silburn P, Mellick G, Dissanayaka N, Mengersen K.

Stat Methods Med Res. 2012 Dec;21(6):563-83. doi: 10.1177/0962280210391012.

Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: a study from India.

Das G, Misra AK, Das SK, Ray K, Ray J.

Neurobiol Aging. 2012 Jul;33(7):1485.e9-15. doi: 10.1016/j.neurobiolaging.2010.10.016.

Current status and future directions of gene expression profiling in Parkinson's disease.

Greene JG.

Neurobiol Dis. 2012 Jan;45(1):76-82. doi: 10.1016/j.nbd.2010.10.022. Review.

Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease.

Polito C, Berti V, Ramat S, Vanzi E, De Cristofaro MT, Pellicanò G, Mungai F, Marini P, Formiconi AR, Sorbi S, Pupi A.

Neurobiol Aging. 2012 Jan;33(1):206.e29-39. doi: 10.1016/j.neurobiolaging.2010.09.004.

Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD-PD spectrum diseases.

Wingo TS, Rosen A, Cutler DJ, Lah JJ, Levey AI.

Neurobiol Aging. 2012 Jan;33(1):204.e13-5. doi: 10.1016/j.neurobiolaging.2010.08.010.

Late-life hemoglobin and the incidence of Parkinson's disease.

Abbott RD, Ross GW, Tanner CM, Andersen JK, Masaki KH, Rodriguez BL, White LR, Petrovitch H.

Neurobiol Aging. 2012 May;33(5):914-20. doi: 10.1016/j.neurobiolaging.2010.06.023.

Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease.

Filomeni G, Graziani I, De Zio D, Dini L, Centonze D, Rotilio G, Ciriolo MR.

Neurobiol Aging. 2012 Apr;33(4):767-85. doi: 10.1016/j.neurobiolaging.2010.05.021.

Intermittent neural synchronization in Parkinson's disease.

Rubchinsky LL, Park C, Worth RM.

Nonlinear Dyn. 2012 May 1;68(3):329-346.

Sympathetic skin response in Parkinson's disease before and after mental stress.

Giza E, Katsarou Z, Georgiadis G, Bostantjopoulou S.

Neurophysiol Clin. 2012 Apr;42(3):125-31. doi: 10.1016/j.neucli.2011.11.002.

Free-living energy expenditure reduced after deep brain stimulation surgery for Parkinson's disease.

Jorgensen HU, Werdelin L, Lokkegaard A, Westerterp KR, Simonsen L.

Clin Physiol Funct Imaging. 2012 May;32(3):214-20. doi: 10.1111/j.1475-097X.2011.01079.x.

The dietary supplementation of nordihydroguaiaretic acid (NDGA) delayed the loss of climbing ability in Drosophila model of Parkinson's disease.

Siddique YH, Ara G, Jyoti S, Afzal M.

J Diet Suppl. 2012 Mar;9(1):1-8. doi: 10.3109/19390211.2011.630716.

A role for locus coeruleus in Parkinson tremor.

Isaias IU, Marzegan A, Pezzoli G, Marotta G, Canesi M, Biella GE, Volkmann J, Cavallari P.

Front Hum Neurosci. 2012 Jan 3;5:179. doi: 10.3389/fnhum.2011.00179.